<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04163380</url>
  </required_header>
  <id_info>
    <org_study_id>111B</org_study_id>
    <nct_id>NCT04163380</nct_id>
  </id_info>
  <brief_title>Resistance Training and Sex Hormone Concentrations During the Menstrual Cycle</brief_title>
  <official_title>Acute Effects of Resistance Training on Sex Hormone Concentrations on Different Phases of the Menstrual Cycle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern Illinois University Edwardsville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern Illinois University Edwardsville</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although there are numerous studies showing effects of aerobic training on sex hormone
      concentrations, research analyzing the fluctuation of sex hormones in response to resistance
      training (RT) is lacking. The objective of this project is to analyze estradiol (E2) and
      progesterone (P4) responses to an acute resistance training session throughout different
      phases of the menstrual cycle. This proposed research has strong implications for exercise
      prescription and for women in general, but more importantly will allow exercise
      physiologists, coaches, personal trainers, or nutritionists optimize exercise programming
      around women's menstrual cycle.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Participants will be blocked (four participants by block) and then randomized to start in one of the four menstrual cycle phases (EFP, LFP, ELP, or LLP). Their will be complete once they have gone through the four phases.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in estrogen concentrations</measure>
    <time_frame>through study completion, an average of 5 weeks</time_frame>
    <description>Estrogen concentrations will be obtained from blood samples assessed using through ELISA kits</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in progesterone concentrations</measure>
    <time_frame>through study completion, an average of 5 weeks</time_frame>
    <description>Progesterone concentrations will be obtained from blood samples assessed using through ELISA kits</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lean body mass (kg)</measure>
    <time_frame>At baseline: 1 assessment point</time_frame>
    <description>Lean body mass (kg) will be assessed through Dual-energy X-ray Absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat mass (kg)</measure>
    <time_frame>At baseline: 1 assessment point</time_frame>
    <description>Fat mass (kg) will be assessed through Dual-energy X-ray Absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative body fat (%)</measure>
    <time_frame>At baseline: 1 assessment point</time_frame>
    <description>Relative body fat (%) will be assessed through Dual-energy X-ray Absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Skeletal muscle mass (kg)</measure>
    <time_frame>At baseline: 1 assessment point</time_frame>
    <description>Skeletal muscle mass (kg) will be estimated using Dual-energy X-ray Absorptiometry values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory Fitness</measure>
    <time_frame>At baseline: 1 assessment point</time_frame>
    <description>Cardiorespiratory Fitness will be assessed with a cardiopulmonary exercise test using the Bruce protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strength in Bench Press</measure>
    <time_frame>At baseline: 1 assessment point</time_frame>
    <description>Maximal strength bench press will be assessed using one repetition maximum test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Strength in Leg Press</measure>
    <time_frame>At baseline: 1 assessment point</time_frame>
    <description>Maximal strength in leg press will be assessed using one repetition maximum test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in diet</measure>
    <time_frame>through study completion, an average of 5 weeks</time_frame>
    <description>Diet will be assessed using the a 24h dietary recall</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Women's Health</condition>
  <arm_group>
    <arm_group_label>Early Follicular Phase (EFP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Follicular Phase (LFP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Early Luteal Phase (ELP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Late Luteal Phase (LLP)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Resistance Training</intervention_name>
    <description>Participants will exercise at the mid-point of each menstrual cycle phase (EFP- day 4, LFP- day 11, ELP- day 18 and LLP- day 25 for a 28 day menstrual cycle). Training will consist of a warm up. Intensity will be set at 70% of 1RM, and the circuit training will include 7 strength exercises: leg press, rows, back squat, weighted crunches, deadlifts, bench press, and weighted squat jumps. The participant will perform 3 sets f 10 repetitions with 30 seconds of rest</description>
    <arm_group_label>Early Follicular Phase (EFP)</arm_group_label>
    <arm_group_label>Early Luteal Phase (ELP)</arm_group_label>
    <arm_group_label>Late Follicular Phase (LFP)</arm_group_label>
    <arm_group_label>Late Luteal Phase (LLP)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Eumenorrheic females

          -  Age 18-45 years old

          -  BMI of 18.5-34.99 kg/m2

        Exclusion Criteria:

          -  Practice exercise more than 2 days/week in the last 3 months.

          -  Cardiovascular, metabolic, pulmonary or muscular-skeletal condition

          -  Taking medications that affect metabolism (e.g. oral contraceptives)

          -  Irregular menstrual cycles
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Females</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maria Fernandez del Valle, PhD</last_name>
    <phone>6186505905</phone>
    <email>marfern@siue.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Southern Illinois University Edwardsville</name>
      <address>
        <city>Edwardsville</city>
        <state>Illinois</state>
        <zip>62026</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Fernandez del Valle, PhD</last_name>
      <phone>618-650-5905</phone>
      <email>marfern@siue.edu</email>
    </contact>
    <investigator>
      <last_name>Maria Fernandez del Valle, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>October 30, 2019</study_first_submitted>
  <study_first_submitted_qc>November 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2019</study_first_posted>
  <last_update_submitted>February 15, 2020</last_update_submitted>
  <last_update_submitted_qc>February 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Estrogen</keyword>
  <keyword>Progesterone</keyword>
  <keyword>Menstrual Cycle</keyword>
  <keyword>Resistance Training</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

